New research from Auburn University and the U.S. Department of Agriculture (USDA) is shedding light on how “coinfections” – cases where a fish is hit by multiple pathogens at once – are far more devastating to aquaculture than single-pathogen infections.
While traditional fish health studies typically focus on one disease at a time, this collaborative project highlights that “in the real world, it’s never just one thing.” By studying how bacteria and viruses interact, researchers are discovering that these combinations don’t just add to the risk; they multiply it.
Key Findings from the Research:
- Synergistic Lethality: Researchers found that low doses of two different pathogens often result in higher mortality rates than a high dose of a single pathogen. This “weird synergy” means that even relatively minor infections can become fatal when they overlap.
- Order of Infection Matters: The sequence in which a fish is exposed to pathogens (Pathogen A then Pathogen B, or vice versa) significantly changes the mortality patterns. This complicates treatment, as farmers must decide which “fire” to put out first.
- Genetic “Fingerprinting”: By measuring messenger RNA, scientists can see exactly which parts of a fish’s immune system are “turned on” or “off” during a coinfection. They’ve discovered that coinfection doesn’t just cause “more” disease – it effectively creates a different disease with unique immune responses.
- Pathogen Communication: The study is also looking at how pathogens behave when they are near each other. Some bacteria may actually “hold the door open” for others or create specific proteins that leave the host fish more vulnerable to secondary attacks.
Why It Matters
For fish farmers, these findings explain why some disease outbreaks are so unpredictable and difficult to manage with standard protocols. The research, which has focused heavily on major killers of channel catfish like Flavobacterium covae (columnaris), suggests that management strategies need to evolve.
As the project enters its fifth year, the team is expanding its scope to see how common interventions – like vaccines, antibiotics, and probiotics – perform when multiple pathogens are present. The ultimate goal is to move away from “one-size-fits-all” treatments and toward a more sophisticated understanding of the complex “pathobiome” in commercial ponds.